Key Insights

Highlights

Success Rate

83% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 52/100

Termination Rate

11.1%

1 terminated out of 9 trials

Success Rate

83.3%

-3.2% vs benchmark

Late-Stage Pipeline

33%

3 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed with results

Key Signals

83% success

Data Visualizations

Phase Distribution

5Total
Not Applicable (1)
P 1 (1)
P 3 (1)
P 4 (2)

Trial Status

Completed5
Unknown3
Terminated1

Trial Success Rate

83.3%

Benchmark: 86.5%

Based on 5 completed trials

Clinical Trials (9)

Research Network

Activity Timeline